Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

31.25SEK
10:53am EST
Change (% chg)

-1.50kr (-4.58%)
Prev Close
32.75kr
Open
32.80kr
Day's High
32.85kr
Day's Low
30.65kr
Volume
1,163,944
Avg. Vol
322,823
52-wk High
44.27kr
52-wk Low
24.31kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 16.94 192.73 34.59
P/E High - Last 5 Yrs. 17.52 285.47 45.93
P/E Low - Last 5 Yrs. 17.52 93.40 24.19
Beta 0.81 0.81 0.81
Price to Sales (TTM) 6.96 137.31 8.08
Price to Book (MRQ) 2.65 20.28 5.24
Price to Tangible Book (MRQ) -- 27.91 6.43
Price to Cash Flow (TTM) 19.28 126.48 25.98
% Owned Institutions -- 11.77 2.27

Dividends

  Company industry sector
Dividend Yield 0.81 0.28 1.52
Dividend Yield - 5 Year Avg 0.35 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) 0.00 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 60.98 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago 67.97 62.55 7.61
Sales - 5 Yr. Growth Rate -- 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 129.92 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago 382.49 -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate 15.70 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 2.10 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -3.83 -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 51.38 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) 30.31 -- --
EBITD - 5 Yr. Avg -36.86 -233.45 14.67
Operating Margin (TTM) 21.59 -490.18 4.40
Operating Margin - 5 Yr. Avg. -43.06 -250.27 9.99
Pre-Tax Margin (TTM) 14.82 -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -44.64 -256.86 10.24
Net Profit Margin (TTM) 27.39 -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -30.81 -260.25 6.55
Effective Tax Rate (TTM) -84.78 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,468,754 23,887,942 823,803,020
Net Income/Employee (TTM) 2,045,783 -537,326 96,327,335
Receivable Turnover (TTM) -- 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.41 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 11.17 -1.02 10.76
Return on Assets - 5 Yr. Avg. -9.05 -0.09 12.05
Return on Investment (TTM) 12.41 -0.67 13.67
Return on Investment - 5 Yr. Avg. -13.05 2.39 15.78
Return on Equity (TTM) 16.59 -3.38 15.40
Return on Equity - 5 Yr. Avg. -18.16 -1.61 17.04
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.66 -7.95 68 72
13 Week -6.93 -6.18 71 94
26 Week -15.76 -18.58 60 89
52 Week 27.57 25.32 99 90
YTD -2.24 -2.73 82 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.39%
# of Holders: 13
Total Shares Held: 4,812,416
3 Mo. Net Change: 1,541,588
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 1
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.